Enhancing Transfusion Safety: Nurse’s Role by Kyriazi Vasiliki
International Journal of Caring Sciences        2011           September-December       Vol 4     Issue 3      
www.inernationaljournalofcaringscienes.org 
 
114
R E V I E W      P A P E R 
 
 
Enhancing Transfusion Safety: Nurse’s Role 
 
 
Kyriazi Vasiliki, Hematologist, MD, MSc 
Transfusion Service, “Pammakaristos” General Hospital, Athens, Greece 
  
Corresponding author: Kyriazi Vasiliki,  Doxara 2, 11143, Athens, Greece 
E-mail: kyr.vicky@hotmail.com ,     Phone Number: +302102584869 
 
Abstract 
 
Background: Despite strict clinical measures, there are distinct steps in transfusion process which require acute attention. 
The nurse is responsible for insuring that the right unit is administered to the right patient. Knowledge of risks is essential to 
administer and monitor transfusions safely.  
Aim: This study summarizes the available data concerning transfusion adverse events and provides theoretical and technical 
aspects for improving transfusion practice.  
Methodology: A systematic review in PubMed, MedLine and MDConsult database was conducted. The research limits 
included English texts, referring to transfusion risks and technological means aiming at transfusion safety.  
Results: Blood transfusion is a medical intervention that saves lives and improves the quality of life. The regulations for 
ensuring the availability and assuring the quality of the blood component cannot avoid transfusion errors, placing patients at 
risk. Most frequent errors are attributed to practitioners involved in the clinical transfusion process. Based on reports to 
Serious Hazards of Transfusion (SHOT) the risk of transfusion error is estimated at 1:16,500. Over the last years several 
committees have recommended guidance for enhancing the safety of blood ordering and administration. Moreover, new 
technology like barcode on patient wristband manages to improve the performance in each step.   
Conclusion: Safe transfusion process depends on a series of linked processes and nurses should take specific measures 
referring to pre- and post-transfusion stage. Technological innovations could help patients in need of transfusion therapy. 
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Introduction 
 
Blood components administration is common in 
clinical  practice,  especially  in  surgical  and 
hematological  departments.  Blood  safety  and 
quality regulations refer to the collection, testing, 
processing,  storage  and  distribution  of  human 
blood  (Dzik  WH,  2007).
  Over  the  past  two 
decades,  expanded  blood  donor  screening  and 
pathogen  laboratory  methods  have  greatly 
reduced  the  risk  of  transfusion-transmitted  viral 
infections.  Nowadays,  there  is  a  great  concern 
about transfusion practices in clinical departments 
and nurses have the final opportunity to prevent 
mistransfusion,  through  the  final  bedside  check 
(Mole LJ, Hogg G, Benvie S, 2007).  
According to SHOT program (Serious Hazards of 
Transfusion)  about  70%  of  all  reported  adverse 
events  are  attributed  to  the  incorrect  transfused 
blood  component.  Furthermore,  half  of  these 
events  involve  more  than  one  error  in  the 
transfusions  process  (Gray  A,  Illingworth  J, 
2005).  
 
Error  risk  in  transfusion  chain  is  estimated  at 
1:16,500  and  an  ABO  incompatible  transfusion 
risk  at  1:100,000,  whereas  the  risk  of  death  is 
about  1:1,500,000  (SHOT,  2003).  Recently 
published  guidelines  recommend  careful  sample 
collection,  pre-transfusion  checking  and  close 
monitoring  of  transfused  patient  (Rowe  R, 
Doughty H, 2000; Hainsworth T, 2004). Nurses 
can reduce the error potential by developing safe 
blood transfusion policies, auditable performance 
standards  and  educational  initiatives  (Gray  A, 
Howell C, Pirie E, 2005).  
 
Methodology 
 
For the purpose of this study, articles are searched 
in PubMed, MedLine and MDConsult database, 
by using the keywords: transfusion, errors, safety, 
nurse  and  technology.  Search  limits  include 
access  to  English  full  texts  with  integrated 
bibliography, published from 2000 to November 
2010.  A  total  of  109  articles,  guideline 
instructions and textbook references are found.  International Journal of Caring Sciences        2011           September-December       Vol 4     Issue 3      
www.inernationaljournalofcaringscienes.org 
 
115
Ninety  reports  involving  organ  transplantation, 
tissue  banking,  transmitted  infections  and 
advanced  methods  concerning  the  decision  to 
transfuse are excluded. 
 
Transfusion Errors 
 
Blood  transfusion  saves  life,  but  an  error  in 
transfusion  process  takes  life.  The  number  of 
transfusion errors is underestimated, because only 
one  third  of  the  adverse  events  have  obvious 
clinical consequences and hospitals do not report 
all  cases  to  Registration  Services.  Transfusion 
process  is  complex  with  a  number  of  critical 
points that offer the possibility of error. Thus, the 
acute  hemolysis  due  to  ABO  incompatibility  is 
the final result of failures having occurred during 
patient  identification,  sample  labelling, 
prescribing blood component, laboratory testing, 
collection  and  administration  (Stainsby  D  et  al, 
2005). In transfusion medicine, errors may be on 
account  of  lack  of  Knowledge  or  incomplete 
information,  but  more  often  result  from 
distraction,  fatigue,  or  inattention  (Dzik  WH, 
2007).  While  it  is  a  medical  responsibility  to 
prescribe  blood  components,  the  completion  of 
the  request  form,  the  pre-transfusion  sampling 
and the administration of the component can be 
delegated to nursing staff (Sullivan P, 2005). 
 
Request and prescription errors 
 
A  decision  to  transfuse  should  be  based  on 
clinical  symptoms  and  signs  supported  by 
laboratory findings. Recent guidelines direct that 
blood should not be administered prophylactically 
and the threshold of transfusion is a hemoglobin 
level 7.00 to 8.00 gr/dL (British Committee for 
standards  in  Haematology-Blood  Transfusion 
Task Force, 2001). A transfusion which does not 
fulfill  certain  criteria  can  result  in  major 
morbidity  and  mortality  and  increase  blood 
shortage.  Mismatches  between  laboratory  report 
and  clinical  symptoms  must  be  carefully 
examined,  as  incorrect  results  may  be  due  to 
unsuitable  samples  or  analytical  errors. 
Telephoned reports may be wrongly transcribed 
or assigned to the wrong patient. Adverse events 
may  also  occur  from  failure  to  provide  the 
transfusion  service  with  information  regarding 
patient’s  transfusion  history  or  special  blood 
requirements  (e.g.  antigen  or  cytomegalovirus–
negative  blood,  irradiation  or  leukodepletion  of 
products) (Stainsby D et al, 2005). 
After  the  decision  to  transfuse,  a  request  form 
should be completed and send to the transfusion 
service. The petition form includes the patient’s 
full  name,  age,  disease,  transfusion  history  and 
previous  pregnancies.  The  necessity  of 
transfusion therapy and the need of special blood 
procedures  like  irradiation  should  also  be 
reported.  Errors  often  occur  because  blood  or 
other components are ordered for wrong patient 
or patient is transfused with no irradiated blood 
(Sullivan P, 2005). 
Moreover,  before  administering  the  blood 
component, a consent form should be signed by 
the  patient  or  qualified  representative  in  urgent 
situations or when the patient is unable to make 
that decision. The decision to transfuse should be 
recorded in the patient’s case notes and the blood 
prescription should provide instructions regarding 
the  pre-medication,  rate  and  volume  of 
transfusion. (British  Committee for  standards  in 
Haematology–Blood  Transfusion  Task  Force, 
2001; Sazama K, 2007). 
 
Errors in collection of pre-transfusion samples 
 
In  most  countries,  the  blood  sample  from  the 
prospective  recipient  is  taken  for  ABO  and 
Rhesus  testing,  antibody  screening  and 
crossmatch.  Errors  in  blood  sampling  are 
especially dangerous as they can initiate a wrong 
process.  It  was  estimated  that  14%  of  ABO 
incompatible  transfusions  were  due  to  sample 
collection  errors  (Linden  JV  et  al,  2000). 
Practices resulting in wrong blood in tube include 
labelling of sample tubes away from the bedside, 
failure to check patient’s identity and the use of 
preprinted  labels  (Cummins  D  et  al,  2000).  A 
multicenter  international  study  of  650,000 
samples  submitted  to  transfusion  services 
reported  that  the  median  frequency  of 
miscollected samples was 1 in 1986 (Dzik WH et 
al, 2003). In addition, poor techniques in blood 
sampling  can  result  in  erroneous  hemoglobin 
result and inappropriate decision to transfuse with 
severe consequences.  
In order to avoid the risk of sampling errors, nurse 
staff  should  have  the  appropriate  training. 
Samples  must  be  taken  from  a  free  flowing 
venipancture site, the tube filled to capacity and 
adequately  mixed.  (Stainsby  D  et  al,  2005). 
Patient’s identity should be carefully checked and 
the  sample  labelling  should  be  done  before 
leaving the patient. The label details include: date, 
patient’s full and patronymic name, date of birth, International Journal of Caring Sciences        2011           September-December       Vol 4     Issue 3      
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code number, clinic origin and signature (Gray A, 
Illingworth J, 2005). 
 
Laboratory errors 
 
Approximately 30% of wrong blood events arise 
in the laboratory (Linden JV et al, 2000). These 
errors  usually  take  place  outside  of  core  hours, 
when there is limited staff number that may be 
inexperienced  and  work  under  pressure. 
Furthermore,  problems  in  interpretation  and 
documentation could emerge due to urgent blood 
grouping  using  manual  techniques.  Adequate 
staffed  transfusion  service  throughout  the  24-
hours period is essential for reducing laboratory 
errors  and  “out-of-hours”  transfusion  request 
should  be  restricted  to  those  that  are  clinically 
imperative (Stainsby D et al, 2005). 
 
Errors in blood collection and administration 
 
The stage of greatest risk in transfusion chain is 
collection  of  the  blood  component  from  blood 
refrigerator and its administration to the patient. 
Errors at these stages constituted 40% of wrong 
blood events reported to SHOT in 2003 and it is 
estimated that 1 in 14,000 transfusions involved 
ABO-incompatibility. Blood checking away from 
the bedside, distraction of nursing staff, patient’s 
wristband  missing,  defaced  or  hidden  and 
transfusion  performance  in  clinical  urgent 
situations are some of the factors that facilitate the 
occurrence  of  these  events  (Stainsby  D  et  al, 
2005). Undoubtedly, these errors can be fatal and 
only  good  luck  sometimes  prevents  a  bad 
outcome.  
Consistently, the commonest error is a failure to 
carry out a pre-transfusion “bedside” check. The 
basic  elements  of  this  check  include  positive 
patient identification, matching wristband to the 
blood  compatibility  label,  matching  patient’s 
identity  with  blood  request  form  and  review  of 
compatibility  and  expiry  data  information.  The 
pre-transfusion  checking  must  be  repeated  for 
each  component  administered.  If  there  are  any 
discrepancies  at this  point,  the transfusion  must 
not start until they have been resolved (Gray A, 
Illingworth J, 2005; Dzik WH, 2007). 
 
Practical Aspects For Nursing Care 
 
Administration sets and filters 
Filters  are  used  to  retain  clots  and  other  debris 
from  blood  components.  Standard  in-line  blood 
filters have a pore size of 170 microns. The set 
could  not  be  used  for  longer  than  four  hours, 
because  the  risk  of  bacterial  contamination  is 
increased  substantially.  Sets  for  platelets  and 
fresh frozen plasma infusion have a shorter line 
and smaller filter (Mole LJ, Hogg G, Benvie S, 
2007). 
 
Intravenous infusion 
Blood and other components are usually infused 
to  an  adult  through  18-20  gauge  needle.  A  24-
gauge or larger thin-walled scalp vein needle may 
be used for children and adults whose large veins 
are inaccessible. During transfusion process, only 
0.9%  sodium  chloride  solution  can  de 
administered. Other solutions or medications must 
not  be  added  to  blood  components  (British 
Committee for standards in Haematology–Blood 
Transfusion Task Force, 2001). 
 
Leukocyte reduction filters 
Special “third generation” filters are available that 
can  reduce  effectively  the  leukocyte  number  in 
the red cells or platelets to less than 5×10
6, a level 
that reduces the risk of HLA allo-immunization 
(Human  Leukocyte  Antigen,  HLA), 
cytomegalovirus transmission, Creutzfeld – Jacob 
disease  and  non-hemolytic  reactions.  The 
available leukodepletion methods are divided into 
pre-storage  and  selective  leukodepletion,  the 
former is performed during blood collection, the 
later uses bedside filters. There are special filters 
for red cells and platelets that differ in technology 
used for leukocyte removal and should be used 
according to manufacturer’s directions (Ratko TA 
et al, 2001). 
 
Infusion devices 
Electromechanical  infusion  devices  permit 
infusion  at  controlled  rate  and  may  alert  the 
process  when  a  problem  has  occurred.  In  some 
cases red cells may undergo hemolysis, however, 
without clinical significance. 
 
External pressure devices 
They  are  used  to  infuse  large  quantities  of  red 
cells in a short period of time. These devices are 
coupled  with  wide  lumen  catheter  and  the 
maximum  pressure  should  be  300mmHg. 
Standard  sphygmomanometers  apply  uneven 
pressure and should not be used. 
 
Blood warmers 
These  devices  are  used  in  urgent  cases,  which 
demand  an  elevated  flow  rate  (>50  ml/kg/h  in 
adults and >15 ml/kg/h in children) and in case of 
cold-agglutinins  presence.  They  also  used  to International Journal of Caring Sciences        2011           September-December       Vol 4     Issue 3      
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prevent hypothermia, cardiac arrhythmias and/or 
arrest when a large amount of blood is transfused. 
Currently, there are many available devices on the 
market  like  countercurrent  heat  exchange,  dry 
heat,  thermostatically  controlled  water  bath,  in-
line  microwave.  Warming  devices  must  be 
equipped  with  a  warning  system  to  prevent 
excessive heat (British Committee for standards 
in  Haematology–Blood  Transfusion Task  Force, 
2001). 
. 
Duration and infusion rate 
The  appropriate  transfusion  rate  depends  on 
patient’s condition and should be specified by the 
physician. The transfusion must be started slowly 
(2  ml/min)  for  the  first  15  minutes,  because  of 
increased  risk  of  severe  reaction  during  this 
period. A unit of red cells must be infused over 3-
4  hours;  platelet  and  fresh  frozen  plasma  are 
administered  at  approximately  50  ml/hour  over 
the critical period and if no problem is observed 
the rate can be increased (Gray A, Howell C, Pirie 
E, 2005). 
 
Patient Monitoring 
Every  patient  receiving  a  transfusion  should  be 
monitored throughout the process and nurse’s role 
at this stage is crucial. The patient’s vital signs 
(temperature,  heartbeat  pulses,  respiratory  rate 
and  blood  pressure)  should  be  checked  and 
recorded before transfusion and 15 minutes after 
the initiation of the process and then every hour. 
The rate of component’s flow should be regulated 
according  to  physician’s  orders  (Gray  A, 
Illingworth J, 2005).  
Patient should be observed periodically for signs 
and  symptoms  of  transfusion-related  reactions. 
Upon  completion  of  the  transfusion,  vital  signs 
should be checked and compared with previous 
values.  
Equally important is the laboratory assessment of 
transfusion  therapy,  measuring  hemoglobin, 
platelet  count,  PT/INR,  APTT  and  fibrinogen. 
The  time  of  such  testing  may  vary  for  each 
patient,  depending  on  clinical  condition  (New 
York  State  Council  on  Human  Blood  and 
Transfusion Services and New York State Board 
for Nursing, 2008). 
 
Transfusion Reactions 
Transfusion-related  reactions  usually  are 
underestimated because many symptoms are not 
specific.  The  fatality  rate  is  1  to  1.2  cases  per 
100,000  patients  who  receive  a  transfusion 
(Sazama K, 1990). 
 Generally,  they  can  be  classified  as  acute  or 
delayed. Acute reactions occur during transfusion 
or  within  hours  after  transfusion  completion. 
Common  clinical  manifestations  include  fever, 
chills,  nausea,  vomiting,  diarrhea,  flushing, 
itching,  urticaria,  bronchial  wheezing,  dyspnea, 
headache,  hypertension,  chest  pain,  backache, 
circulatory  collapse,  respiratory  failure,  shock 
(Cherry T, 2008). In case of delayed transfusion 
reactions, symptoms and signs are observed in the 
days,  months  or  even  years  following  a 
transfusion  and  could  not  be  explained  by  the 
patient’s medical condition. Clinical presentation 
of the later events usually consist of fever, rash, 
elevated liver functions, jaundice, elevated lactate 
dehydrogenase,  bleeding  disorders  (Brecher  M, 
2005).  
 
Acute Reactions (Hoffman R, 2005). 
A)  Immune- mediated reactions 
•  Acute  hemolytic  reaction  due  to 
incompatibility  between  donor’s  and  patient’s 
blood 
•  Febrile,  non-hemolytic  reactions  related  to 
infused white blood cells or cytokines 
•  Allergic reactions (mid) to plasma proteins  
•  Allergic  reactions  (severe)  due  to  antibody-
antigen reaction 
•  Transfusion-related  acute  lung  injury  
(TRALI syndrome) due to reaction between donor 
HLA or white blood cell antibody and recipient 
leukocyte 
 
B)  Non- immune- mediated reactions 
•  Bacterial contamination of blood component 
•  Circulatory  overload,  when  the  blood 
administration  is  faster  than  the  circulation  can 
accommodate  
•  Air emboli, due to air pumped into patients by 
roller  pumps  contained  in  various  transfusion 
devices 
•  Hypothermia,  in  case  of  rapid  infusion  of 
large quantities of refrigerated blood  
 
Delayed Reactions (Hoffman R, 2005). 
A)  Immune-mediated reactions 
•  Delayed  hemolytic  reaction  due  to  an 
erythrocyte  antibody,  developed  as  a  result  of 
pregnancy or transfusion in the past 
•  Allo-immunization to erythrocytes antigens 
•  Allo-immunization  to  HLA  and  HPA              
( Human Platelet Antigens, HPA) 
•  Graft-vs-host  disease,  when  donor  T-
lymphocytes attack recipient tissues International Journal of Caring Sciences        2011           September-December       Vol 4     Issue 3      
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•  Post-transfusion purpura due to the antibody 
presence against foreign platelet antigen 
•  Immunomodulatory effects 
 
B)  Non-immune- mediated  reactions 
•  Iron overload 
•  Transmission  of  infectious  agents  (e.g. 
viruses, parasites)  
 
Patients  should  be  award  about  the  possible 
adverse  events  during  transfusion  process  and 
encouraged  to  notify  nursing  staff  if  they  have 
symptoms  like  shivering,  flushing,  pain  or 
shortness  of  breath.  If  the  reaction  occurs,  the 
transfusion  must  be  stopped  immediately  and 
doctor must be informed. Normal saline infusion 
is useful in order to maintain intravenous line and 
patient’s  hemodynamic  stability  (Stainsby  D, 
2007).
 
Nurse  must  reconfirm  patient  and  unit 
identification. Patient’s blood and urine specimen 
along with the remaining blood unit must be send 
to the Blood Bank. The reaction must be recorded 
in the patient case notes.  
 
The Application of New Technology 
Over the last few years, technological innovations 
have  improved  transfusion  conditions  and 
restricted  the  risk  of  human  errors.  Machines 
cannot  be  distracted,  do  not  make  arbitrary 
thoughts that lead to error and are much better to 
repetitive  matching.  The  challenge  for 
practitioners  is  the  appropriate  use  of  the 
technology,  which  is  based  on  specific  training 
courses. 
 
Technological  Advances  in  Blood  Collection 
And Labeling 
Handheld  devices  identify  patient’s  data  from 
wristband and are coupled with small automated 
printers  that  create  specimen  labels  using  data 
taken directly from patient’s wristband. (Aller R, 
2005) 
 
Technological Advances in Blood 
Administration  
Barcode at the bedside is a stable and inexpensive 
mean  of  machine-readable  identification.  It  is 
based  on  the  use  of  special  wristbands  with  a 
barcode,  whereas  the  unit  label  is  of  the  same 
structure. At the bedside a nurse scans both the 
patient  and  the  unit  using  a  handheld  reader to 
verify the accuracy of the bedside check.  Barcode 
technology  is  very  useful  for  “one-day” 
transfusion depended patients who enter hospital 
(Sandler SG, Langeberg A, Dohnalek L, 2005). 
Radiofrequency identification technology (RFID) 
uses a chip holding much more data than barcode 
system,  which  include  blood  group,  allo-
antibodies detection and special blood needs. In 
addition  RFID  chips  are simply  interrogated  by 
proximity to a passive electronic reader without 
any user’s contribution (Dzik WH, 2007) 
 
Discussion 
 
Nurses have a crucial role in transfusion process 
beginning with blood sampling and ending with 
blood  administration.  Errors  that  result  in 
inappropriate transfusion remain the largest risk 
and  usually  occur  when  details  of  patient’s 
identification  are  overlooked.  Nearly  all 
transfusion  steps  can  be  complicated  by  life-
threaten  mistakes  starting  with  prescription  and 
request form, sampling and labelling, laboratory 
testing,  collection  and  administration  of  blood 
product.  Nursing  training  courses could  educate 
on  transfusion  risk  elimination  and  facilitate 
nurse’s  intervention  and  decision  making.  The 
knowledge  of  pathophysiology  of  transfusion 
reactions,  symptoms  and  management  could 
improve patient’s monitoring.  
Nursing  staff  should  be  aware  about  recent 
technological  achievements  in  planning  and 
management  of  transfusion  medicine.  Recent 
technological  advances  improve  performance  in 
each  point  of  transfusion  chain.  Technology 
concerning  pre-transfusion  blood  labelling  and 
barcode  identification  system  has  successfully 
assured the process.  The above combined with 
the  development  of  technical  skills  and  the 
rational  use  of  available  devices  can  improve 
nursing care. The big challenge is to familiarize 
practitioners  with  the  use  of  the  available 
resources in routine practice.  
Good  transfusion  practices,  successful 
educational initiatives and references systems of 
adverse  events  could  manage  to  reduce  the 
number  of  transfusion  errors.  Thus,  clinical 
guidelines,  quality  assurance  programs  and 
systems  for  reporting  and  investigating  adverse 
events  should  be  available  in  all  hospitals, 
preventing harmful consequences.  
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